DZDaria O. Zhukova

Daria O. Zhukova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daria O. Zhukova has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical and functional predictors of pulmonary hypertension in patients with idiopathic pulmonary fibrosis

    by A. A. Proshkina, N. A. Tsareva, G. V. Nekludova, K. S. Ataman, D. O. Zhukova, Z. M. Merzhoeva, V. V. Gaynitdinova, S. N. Avdeev, А. А. Прошкина, Н. А. Царева, et al.

    Introduction . Idiopathic pulmonary fibrosis (IPF) is frequently complicated by pulmonary hypertension (PH), the prevalence of which reaches 50–80% among patients awaiting lung transplantation. At the same time, the accuracy of transthoracic echocardiography as the main screening method for PH in patients with IPF is limited, which determines the need for simple non-invasive functional tests to select patients for further in-depth evaluation. Aim . To determine the clinical and functional predictors of pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Materials and methods. The study included 121 patients with IPF. Based on echocardiography findings, the patients were divided into two groups: without PH (PASP Results . The groups did not differ significantly in age, sex, BMI, or smoking status. In patients with PH, cardiovascular events were significantly more frequent (59 vs. 26%, p < 0.001), as was chronic heart failure (55 vs. 23%, p = 0.001). The Charlson Comorbidity Index (p = 0.027) and dyspnea severity according to the mMRC scale (p = 0.022) were higher in the PH group. Absolute DLCO was lower in the PH group (8.5 vs. 10.1 mL/min/mmHg, p = 0.041). The level of desaturation during the 6MWT was higher, and post-6MWT SpO₂ was lower in the PH group (p = 0.002 and p = 0.001, respectively). ROC analysis identified the following cut-off values: post-6MWT SpO₂ 9%, post-6MWT SpO₂ <84%) may be utilized for screening purposes.

  • Open Access

    Echocardiographic determinants of pulmonary hypertension in patients with idiopathic pulmonary fibrosis: Association with clinical and functional status

    by A. A. Proshkina, N. A. Tsareva, G. V. Nekludova, K. S. Ataman, D. O. Zhukova, Z. M. Merzhoeva, V. V. Gaynitdinova, S. N. Avdeev

    Introduction . Pulmonary hypertension (PH) frequently complicates the course of idiopathic pulmonary fibrosis (IPF) and worsens its prognosis; however, echocardiographic signs of right heart chamber remodeling and clinical and functional factors associated with systolic pulmonary artery pressure (PASP) level in IPF remain insufficiently studied. Aim . To characterize echocardiographic changes in the right heart chambers in patients with idiopathic pulmonary fibrosis depending on the presence of pulmonary hypertension and to identify clinical and functional factors associated with the value of systolic pulmonary artery pressure. Materials and methods. The study included 121 patients with IPF. Based on echocardiography, patients were divided into groups without PH (PASP < 35 mmHg, n = 35) and with PH (PASP ≥ 35 mmHg, n = 86). Right atrial area (RA area), mean right ventricular diameter (RV diameter), TAPSE, TAPSE/PASP ratio, and left ventricular ejection fraction (LVEF) were assessed. Spearman correlation analysis, univariate and multivariate linear regression analysis with PASP as a continuous variable were performed. Results. The PH group showed larger RA area (17.0 vs 13.5 cm², p < 0.001), larger RV diameter (4.00 vs 3.75 cm, p < 0.001), and a lower TAPSE/PASP ratio (0.438 vs 0.697, p < 0.001) with no difference in absolute TAPSE (p = 0.941). LVEF was slightly lower in the PH group (61% vs 62%, p = 0.016) but remained within normal limits. PASP correlated positively with RA area (r = 0.491, p = 0.019) and desaturation level during 6MWT (r = 0.355, p < 0.001), and negatively with post-exercise SpO₂ (r = -0.336, p = 0.001). DLCO correlated positively with post-exercise SpO₂ (r = 0.347, p = 0.001) and negatively with mMRC (r = -0.338, p = 0.001) and desaturation (r = -0.270, p = 0.014). Univariate linear regression showed associations of PASP with cardiovascular events (β = 10.8), CHF (β = 10.9), desaturation (β = 1.02 per 1%), post-exercise SpO₂ (β = -0.603), mMRC (β = 4.52), LTOT duration (β = 3.74 per year), and LVEF (β = -0.562). In multivariate linear regression, independent determinants of PASP were the Charlson comorbidity index (β = 2.205 per 1 point; p = 0.006), desaturation level (β = 1.153 per 1%; p < 0.001), and LTOT duration (β = 4.281 per year; p = 0.020). Conclusion . In patients with IPF, pulmonary hypertension is associated with right heart remodeling (enlarged RA area, RV diameter) and reduced right ventricular-pulmonary arterial coupling (decreased TAPSE/PASP ratio) despite preserved TAPSE. Independent determinants of PASP value are comorbidity burden (Charlson index), desaturation during exercise, and long-term oxygen therapy duration.

  • Predictors of severe pulmonary hypertension in patients with idiopathic pulmonary fibrosis

    by A. A. Proshkina, N. A. Tsareva, G. V. Nekludova, K. S. Ataman, D. O. Zhukova, Z. M. Merzhoeva, V. V. Gainitdinova, S. N. Avdeev

    Idiopathic pulmonary fibrosis (IPF) is a chronic progressive interstitial lung disease with a poor prognosis. The median survival after diagnosis does not exceed 2 – 3 years. One of the most significant complications of IPF is pulmonary hypertension (PH), the incidence of which is 20 – 84% and increases with the disease advancement. The aim of the study was to comparatively analyze the clinical, functional and echocardiographic characteristics of patients with IPF depending on the degree of PH and to evaluate the diagnostic value of non-invasive parameters for detecting severe PH. Methods . The observational study included patients ( n = 121; median age – 69 years) with verified IPF. Depending on the pulmonary artery systolic pressure (PASP), the patients were divided into 3 groups. Group 1 ( n = 35) included patients without PH (PASP < 35 mmHg). Group 2 ( n = 59) included individuals with moderate PH (PASP 35 – 59 mmHg). Group 3 ( n = 27) included patients with severe PH (PASP ≥ 60 mmHg). Clinical data, Charlson Comorbidity Index, 6-minute walk test (6-MWT), spirometry, diffusing capacity of the lungs for carbon monoxide (DLCO), high-resolution computed tomography (HRCT), and transthoracic echocardiography were assessed. Diagnostic accuracy was determined using ROC analysis, and the association with severe PH was determined using univariate and reduced multivariate logistic regression. Results . As PASP increased, the incidence of cardiovascular events (26% vs 53% vs 74%, respectively; p < 0.001) and chronic heart failure (23% vs 47% vs 70%, respectively; p < 0.001) also grew, dyspnea progressed (modified Medical Research Council dyspnea scale – mMRC – 4 points: 8.6% vs 25% vs 41%, respectively; p = 0.049), desaturation rose during 6-MWT (7% vs 9% vs 12%, respectively; p = 0.002), and the right heart chambers dilated (the tricuspid annular systolic excursion (TAPSE) / PASP ratio was 0.697 vs 0.477 vs 0.317, respectively; p < 0.001). Spirometry parameters and DLCO did not differ between the groups. The degree of desaturation during the 6-MWT had the highest diagnostic value for detecting severe PH (AUC = 0.721: p = 0.005; sensitivity – 80%, specificity – 64% at the threshold > 9%). In the reduced multivariate model, desaturation remained the only independent predictor of severe PH (odds ratio – 1.237; 95% confidence interval – 1.086 – 1.437; p = 0.003). Conclusion . Desaturation > 9% during the 6-MWT serves as a reliable non-invasive criterion for selecting patients with IPF for in-depth examination to detect severe

  • Bronchial asthma in pregnant women

    by V.V. Gaynitdinova, D.O. Zhukova, S.N. Avdeev

    The aim of the article — systematization and analysis of modern data to determine the best management tactics for patients suffering from bronchial asthma during pregnancy. Bronchial asthma (BA) is the most common chronic respiratory tract disease in pregnant women, occurring in 4—12% of women. In recent years, a number of studies and reviews have confirmed that uncontrolled asthma during pregnancy is associated with an increased risk of obstetric and perinatal complications, including preeclampsia, preterm birth, low birth weight, and a higher incidence of respiratory diseases in early childhood. According to cohort studies, up to 48% of pregnant women with asthma experience exacerbations, most frequently during the second trimester, with a peak around the sixth month of gestation. Review articles and clinical guidelines emphasize that the benefits of continuing anti-asthma therapy substantially outweigh potential risks. Current evidence also supports the acceptability of biological agents (anti-IgE, anti-IL-5) in severe asthma, provided that risk is assessed individually and decisions are made jointly with the patient. In clinical practice, regular symptom monitoring, peak expiratory flow measurement, and the use of validated questionnaires (e.g., ACT) are recommended, as these measures help to reduce the frequency of complications and hospitalizations. Thus, timely diagnosis, multidisciplinary follow-up, and personalized therapy are key factors in the successful management of pregnancy in women with bronchial asthma.

  • Open Access

    Heterogeneity of Primary Ciliary Dyskinesia Gene Variants: A Genetic Database Analysis in Russia

    by Elena I. Kondratyeva, Sergey N. Avdeev, Tatiana A. Kyian, Oksana P. Ryzhkova, Yuliya L. Melyanovskaya, Victoria V. Zabnenkova, Maria V. Bulakh, Zamira M. Merzhoeva, Artem V. Bukhonin, Natalia V. Trushenko, et al.

    Primary ciliary dyskinesia (PCD) is a rare hereditary disorder belonging to the group of ciliopathies, with autosomal recessive, autosomal dominant, and, less frequently, X-linked inheritance patterns. The aim of this study was to investigate the genetic heterogeneity of the Russian population of PCD patients based on national registry data. The study included patients with PCD confirmed by molecular genetic testing. Quantitative data were analyzed using non-parametric statistical methods. Differences were considered statistically significant at p < 0.05. The study included 109 patients with PCD. Molecular genetic testing identified pathogenic variants in 29 autosomal recessive genes. The analysis of pathogenic variant distribution in the Russian PCD cohort revealed the highest number of changes in the DNAH5 and DNAH11 genes. 26 genetic variants in 13 genes were identified for the first time in the Russian population. Variants in the DNAH5 gene were significantly more frequent in Kartagener’s syndrome (KS) patients (32/55%) compared to those without KS (11/21.5%) (χ2 = 12.8; p = 0.0004; OR = 4.48). Preliminary data indicate that the frequency spectrum of DNAH5 and DNAH11 genes in Russian patients is similar to international trends. Additionally, there is an accumulation of pathogenic variants in the DNAH5, DNAH11, CCDC39, and CFAP300 genes.


  • The case of a patient with Mounier-Kun syndrome

    by Z.M. Merzhoeva, V.V. Gainitdinova, Z.G. Berikkhanov, K.S. Ataman, D.O. Zhukova, S.N. Avdeev

    Mounier-Kuhn syndrome (MKS) is a rare disease characterized by significant enlargement of tracheobronchial tree, recurrent cough and lower respiratory tract infections. Condition is typically diagnosed through imaging techniques such as computed tomography (CT) scans of the chest and bronchoscopy as well. There are asymptomatic or symptomatic cases in the disease while symptoms can be varied from minimal with preserved lung function to severe, including respiratory failure with recurrent pneumonia and bronchiectasis. Therapy is mainly symptomatic and aimed to manage symptoms. Surgery rarely has a place in the treatment of MKS. Although in the world literature reports of surgical interventions in some patients with MKS surgery have been presented, this type of treatment has not been widely adopted. Due to the lack of specific features in the clinical presentation of the condition, it should be taken into consideration in patients with recurrent episodes of pneumonia and frequent exacerbations of chronic bronchitis. This particular case is presented the patient with non-specific symptoms in the form of a non-productive cough and recurrent episodes of suffocation attacks. To evaluate the patient’s condition, CT of the chest and bronchoscopy are performed. These tests revealed tracheobronchomegaly and tracheal diverticula, which are both associated with the condition.